(Q43466708)

23 November 2017

IL-27 renders DC immunosuppressive by induction of B7-H1. (English)

1 reference

23 November 2017

Svetlana Karakhanova

1

1 reference

23 November 2017

Tanja Bedke

series ordinal

2

1 reference

23 November 2017

Alexander H Enk

series ordinal

3

1 reference

23 November 2017

Karsten Mahnke

series ordinal

4

1 reference

23 November 2017

23 February 2011

1 reference

Journal of Leukocyte Biology

23 November 2017

1 reference

23 November 2017

89

1 reference

23 November 2017

6

1 reference

23 November 2017

837-845

1 reference

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

23 November 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Development of Th1-type immune responses requires the type I cytokine receptor TCCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

The biology and therapeutic potential of interleukin 27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Regulation of immune responses by interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

B7-H1 pathway and its role in the evasion of tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

The balance of immune responses: costimulation verse coinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

IL-27 inhibits the development of regulatory T cells via STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.1209788

21 January 2018

Identifiers

DOI

10.1189/JLB.1209788

1 reference

23 November 2017

1 reference